Telix Pharmaceuticals logs US$477M half-year revenue
Telix Pharmaceuticals (ASX:TLX) reported group revenue of US$477 million for the first half of 2026.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Telix Pharmaceuticals (ASX:TLX) reported group revenue of US$477 million for the first half of 2026.
The Singapore International Commercial Court froze about S$75 million in Bitcoin (CRYPTO:BTC) and USD Coin (CRYPTO:USDC) over a transfer dispute.
Fairshake affiliates spent more than $1.5 million on four US races after a supported candidate lost in Michigan.
H100 Group reported a $26 million first-half loss as falling Bitcoin (CRYPTO:BTC) prices reduced the value of its holdings.
Goodman Group (ASX:GMG) posted an operating profit of $2.67 billion for fiscal 2026, up 15.7%.
Injective Institutional Services, an affiliate of Injective (CRYPTO:INJ), has received effective SEC transfer agent registration.
Global logistics business Brambles (ASX:BXB) posted full-year sales revenue of US$7.05 billion and underlying profit of US$1.50 billion.
Jaguar Health (NASDAQ:JAGX) reported second-quarter 2026 net revenue of $1.2 million, down 59% year over year, following the U.S. commercialization transfer of Mytesi and Canalevia-CA1 to Future Pak affiliate Woodward Specialty.
Top Wealth Group Holding (NASDAQ:TWG) reported unaudited first-half 2026 revenue of $6.1 million, up 48% from $4.2 million a year earlier, driven mainly by expansion of its premium wine distribution business.
Datavault AI (NASDAQ:DVLT) reported second-quarter 2026 revenue of $6.7 million, up $5 million or 287% year over year, as the company expanded its data monetization and tokenization platforms.